1681 — Consun Pharmaceutical Cashflow Statement
0.000.00%
- HK$4.89bn
- HK$1.90bn
- CNY2.59bn
- 99
- 88
- 82
- 100
Annual cashflow statement for Consun Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 134 | 584 | 696 | 746 | 864 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 457 | 19.7 | -6.42 | -40 | -37.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -280 | 192 | -36.9 | 165 | -84.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 383 | 867 | 726 | 948 | 819 |
Capital Expenditures | -180 | -53.7 | -98.3 | -51.6 | -52.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 69.8 | 28 | -200 | -317 | -179 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -110 | -25.7 | -298 | -369 | -232 |
Financing Cash Flow Items | -34.9 | -21.4 | -12.9 | -10.9 | -27.5 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -157 | -280 | -167 | -342 | -280 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 113 | 557 | 256 | 254 | 298 |